Polycystic ovarian syndrome-current pharmacotherapy and clinical implications
Rumaisa Rashid(University of Kashmir), Ghulam Nabi Bader(University of Kashmir), Suhail Ahmad Mir(Khalifa University of Science and Technology), Ozaifa Kareem(University of Kashmir), Fiza Amin(Sher-i-Kashmir Institute of Medical Sciences), Rifat Ara(Sher-i-Kashmir Institute of Medical Sciences), Tabassum Ali(University of Kashmir), Anjum Malik(Sher-i-Kashmir Institute of Medical Sciences)
Cited by 142
Related Papers
Flavonoids as promising molecules in the cancer therapy: An insight
|Current Research in Pharmacology and Drug Discovery|2023|120
Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
|Molecules|2022|56
Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer
|Pharmaceuticals|2023|34